JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 30 No. 2 150-156
© 1989 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishizawa, S.
Right arrow Articles by Konishi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishizawa, S.
Right arrow Articles by Konishi, J.

Regional Dynamics of N-Isopropyl-(123I)p-iodo-Amphetamine in Human Brain

Sadahiko Nishizawa, Shuji Tanada, Yoshiharu Yonekura, Toru Fujita, Takao Mukai, Hideo Saji, Hidenao Fukuyama, Toshihiko Miyoshi, Kiyoshi Harada, Masatsune Ishikawa, Haruhiko Kikuchi and Junji Konishi

Department of Radiology and Nuclear Medicine, Department of Neurology and Department of Neurosurgery, Kyoto University School of Medicine, Kyoto, Japan

Correspondence: For reprints contact: Yoshiharu Yonekura, MD, Dept. of Radiology and Nuclear Medicine, Kyoto University School of Medicine, Shogoin, Sakyo-ku, Kyoto 606, Japan.

ABSTRACT

Regional cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine (IMP) in the human brain were studied using a multi-detector single photon emission computed tomography (SPECT) scanner in 35 subjects both normal and with a variety of neurological conditions. Distribution of IMP in the brain was also compared with regional cerebral blood flow (CBF) measured by positron emission tomography (PET) in 15 of these 35 cases. A significant regional difference in temporal changes of radioactivity was observed among normal brain structures. A rapid increase with early washout of the tracer was shown in the cerebellum and the occipital cortex, while the basal ganglia revealed a relatively slow increase and prolonged retention, indicating the regional difference in extraction and/or retention of IMP among the cerebral tissues. In cases with unilateral hypoperfusion, the percentage of the activity in the lesion to that in the contralateral normal cortex on the early SPECT was correlated well with that on CBF measured by PET (r = 0.870, p < 0.001). However, the contrast on the SPECT image decreased with time after injection; 84.0 ± 7.4% on the SPECT at 5–20 min scan, 87.6 ± 7.6% at 35–50 min scan and 96.2 ± 6.3% at 5 hr scan. In a case with a brain tumor having high blood flow documented by PET, increased accumulation of IMP was observed in the tumor on the early images obtained within 20 min followed by a rapid washout. These findings suggested altered extraction and/or retention of IMP in normal and diseased tissues, and these factors should be considered for the assessment of distribution and redistribution of IMP.




This article has been cited by other articles:


Home page
JNMHome page
A. M. Catafau
Brain SPECT in Clinical Practice. Part I: Perfusion
J. Nucl. Med., February 1, 2001; 42(2): 259 - 271.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1989 by the Society of Nuclear Medicine.